After reporting fourth-quarter earnings that came up short of expectations, shares of Aratana Therapeutics (NASDAQ: PETX), a biotech company focused on pet health, fell by 21% as of 1:40 p.m. Tuesday.
Here’s a review of the headline numbers from the fourth quarter:
Image source: Getty Images.